Associate Professor Ruth Colagiuri, founder of the Juvenile Arthritis Foundation Australia, whose grandchild lives with arthritis, told BioPharmaDispatch that the announcement was excellent news for the community because it an important treatment option affordable for more families. …
'Juvenile arthritis is one of the most under-recognised, misunderstood, and neglected childhood
December 11, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Pilot study confirms adjunct NB-UVB needed to activate repigmentation in vitiligo
June 18, 2025 - - Australian Biotech -
Montu pushes for national standards at Productivity Commission inquiry
June 17, 2025 - - Latest News -
Canadian appointed to lead New Zealand's Pharmac
June 17, 2025 - - Latest News -
US FDA approves CSL's treatment for hereditary angioedema
June 17, 2025 - - Latest News -
Australia's system is more uniform than the US, but not uniformly better
June 17, 2025 - - Latest News -
Australian company secures FDA approval to progress development of CAR-T therapy
June 16, 2025 - - Latest News -
These systems are and always have been more similar than most realise
June 16, 2025 - - Latest News